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Abstract
Background: Hypertension and diabetes mellitus, two of  the leading risk factors for atherosclerosis, are associated with numer-
ous complications, including heart attacks and strokes. 
Aim: This study established the prevalence and determinants of  isolated systolic hypertension (ISH) in diabetes mellitus patients 
visiting the Tamale Teaching Hospital.
Materials and methods: In this purposive cross-sectional study, 107 diabetes mellitus patients were recruited from the out-pa-
tient diabetes clinic of  the Tamale Teaching Hospital (TTH). Blood and urine samples were collected for the estimation of  
fasting blood glucose (FBG) and routine urinalysis respectively. A well-structured pre-tested questionnaire was used to obtain 
socio-demographic data and clinical history of  participants, and their blood pressure measured with a mercury sphygmoma-
nometer.
Results: The prevalence of  ISH among the participants was 37.4%. Mean age and FBG were significantly higher among partici-
pants with ISH than the normotensives (56.20 ± 10.60 v 48.44 ± 11.6, P= 0.022; and 8.80 ± 3.06 v 6.01 ± 0.50, P= 0.034 respec-
tively). Type of  diabetes mellitus was associated with ISH (P= 0.010) and age was a risk factor of  ISH (OR= 1.057, P= 0.008). 
Conclusion: Isolated systolic hypertension was prevalent in 37.4% of  diabetes mellitus patients and was associated with older 
age. Effective measures should, therefore, be instituted to prevent ISH in patients with type 2 diabetes especially the elderly.
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Introduction
Diabetes mellitus is a clinical syndrome associated with 
insulin deficiency, inefficiency or both1. More than 70 per 
cent of  people with diabetes lived in low and middle in-
come countries, with prevalence increasing dramatically 
in Africa with an estimated 10.4 million people with the 
condition in 20072. Diabetes mellitus is associated with an 
increased cardiovascular risk, and hypertension and ac-
celerates morbidity and mortality markedly in these pa-
tients3.
Hypertension is already evident in most patients with 
type 2 diabetes at the time of  diagnosis.
Isolated systolic hypertension (ISH), is defined as systolic 
blood pressure (SBP) ≥140 mm Hg and diastolic blood 
pressure (DBP) <90 mm Hg4. Central obesity is a well-
known risk factor for both diabetes diabetes mellitus and 
hypertension, and is thought to be a common pathway 
whereby obesity affects both diseases. Hypertension and 
diabetes substantially share common pathways such as 
obesity, inflammation, oxidative stress, insulin resistance, 
and mental stress5. 
Isolated systolic hypertension is the most prevalent type 
of  hypertension in adults, occurring either de novo or 
as a development after a long period of  systolic-diastolic 
hypertension with or without treatment6. Several studies 
have demonstrated a high incidence of  hypertension in 
type 2 diabetes mellitus or both type 1 and 2 diabetes mel-
litus5,6,7. However, most of  these studies looked at both 
diastolic and systolic hypertension among patients with 
diabetes. 
Also, there is paucity of  data on the prevalence of  isolat-
ed systolic hypertension among diabetes patients (both 
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type 1 and type 2) in Ghana and worldwide. This study, 
therefore, sought to determine the prevalence and deter-
minants of  isolated systolic hypertension among diabetes 
patients in the Tamale metropolis of  Ghana.
Materials and methods
Study design/ study site
This purposive cross-sectional study was conducted from 
December 2011 to March 2012 at the Tamale Teaching 
Hospital, (TTH) in the Tamale metropolis of  the North-
ern Region of  Ghana. TTH is the largest health facility 
and the only teaching hospital in the northern parts of  
the country. It has a 400 bed capacity and provides tertia-
ry medical care for people of  the three northern regions 
and beyond.  
Participants
A total of  107 diabetes patients who visited the diabet-
ic clinic of  the hospital within the period were recruited 
for the study. In order to determine the required sample 
size, the formula: n=Z2PQ/d2 was used, where, Z=1.96, 
P=prevalence of  diabetes in Ghana i.e. 0.033 (IDF, 2014); 
Q = 1-P i.e. 0.967 and d = margin of  error i.e. 0.05. Thus, 
the calculated sample size was n = 49. With the minimum 
number to be enrolled being 49, we used 107 individuals 
in this study. A well-structured pretested questionnaire 
was used to collect demographic and clinical data of  pa-
tients. The authorities at the Tamale Teaching Hospital 
and the Institutional Review Board of  University of  Cape 
Coast (UCCIRB) approved the study. Informed written 
consent was sought from the participants before obtain-
ing their data and samples.
Inclusion criteria/exclusion criteria
Type 2 diabetes patients on anti-diabetic therapy but not 
anti-hypertensive therapy and willing to participate were 
included in the study. Diabetes patients diagnosed with 
hypertension or those on anti-hypertensive therapy were 
excluded. Pregnant women, patients on other forms of  
therapy and patients visiting the clinic for the first time 
were excluded.
Anthropometric measurements
The height (to the nearest cm) with height measure (Hua-
nan measuring tape) and weight (to the nearest Kg) with 
a weighing balance (Hospibrand ZT-120, England) were 
measured. The height was taken without the patient wear-
ing footwear and the weight measured wearing light cloth-
ing. The Body Mass Index (BMI) was then calculated by 
dividing weight (Kg) by height squared (m2) and cate-
gorized according to WHO criteria into normal weight 
(BMI 18.5–24.9), underweight (<18.5), overweight (25.0–
29.9), obese (>30.0) 
Blood pressure measurement (using Korotkoff  1 and 5)
Trained personnel using a standard cuff  or a cuff  appro-
priate with the patients size, measured blood pressure 
with a mercury sphygmomanometer and a stethoscope 
(Accoson dekamet, England), after patients had rested 
for at least 15 minutes. This was done in accordance with 
the recommendations of  the American Heart Associa-
tion (Kirkendall et al., 1967). Hypertension status was 
categorized as: optimal (SBP<120, DBP<80); normal 
(SBP= 120-129, DBP= 80-84); high-normal (SBP= 120-
139 or DBP =80-89); Stage 1 hypertension (SBP=140-
159 or DBP=90-99); Stage 2 hypertension (SBP >160 or 
DBP>100); ISH (SBP≥140, DBP<90) (Chobanian et al., 
2003).
Sample collection 
After an overnight fast (8-12 hours), 2 ml of  venous blood 
was collected from each participant into sodium fluoride 
anticoagulated tubes. The sample was centrifuged at 3000 
rpm for 3 minutes and the plasma separated for the es-
timation of  the fasting blood glucose (FBG). A freshly 
voided urine sample was collected from patients into a 
clean, dry, leak-proof  and sufficiently wide necked con-
tainer for urinalysis. All the biochemical parameters of  
routine urinalysis (urine protein, glucose, specific gravity, 
and pH) were determined within two hours of  urine col-
lection.
Estimation of  plasma glucose
The FBG level was estimated using Fortress Diagnostics 
reagents (Fortress diagnostics, Antrim, United Kingdom). 
Principle of  the assay was based on the glucose oxidase/
peroxidase method (Barham and Trinder, 1972) and the 
colour developed was measured with a spectrophotome-
ter (JENWAY, Bibby Scientific Ltd. Dunmow, Essex) at a 
wavelength of  500 nm.
Urinalysis
The urine samples were well mixed and the urine protein, 
glucose, SG and pH were detected using a dipstick (Bero-
test U10, Germany). 
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Statistical analysis
Data was stored in Excel and analyzed using SPSS soft-
ware (version 16.0). Descriptive analysis was performed 
and the results expressed as means and percentages. Mul-
tiple logistic regression was done to examine the predic-
tive factors associated with ISH. P-value < 0.05 was con-
sidered statistically significant.
 Results
Table 1 shows the demographic, clinical and biochemical 
data of  study participants stratified by gender. Out of  the 
107 diabetics, 29(27.1%) were males and 79(72.9%) were 
females. Majority of  both male and female participants 
were in their fifth decade of  life, had an informal occupa-
tion, normal buminuria and type 2 diabetes. Majority of  
the females had ISH and were overweight.
Table 1: Socio demographic, BMI and clinical characteristics of study participants stratified by gender. 
 
 
BMI: Body Mass Index; HPT: Hypertension; ISH: Isolated systolic hypertension 
  




(72.9%) X2 P-value 
Age      n (%) 
     <40 20 (18.7) 4 (13.8) 16 (20.5) 5.356 0.253 
40-49 23 (21.5) 4 (13.8) 19 (24.4) 
  50-59 37 (34.6) 15 (51.7) 22 (28.2) 
  60-69 17 (15.9) 4 (13.80 13 (16.7) 
  ≥ 70 10 (9.3) 2 (6.9) 8 (10.3) 
  
      Occupation   n (%) 
     None 5 (4.7) 2 (6.9) 3 (3.8) 10.372 0.006 
Informal 79 (73.8) 15 (51.7) 64 (82.1) 
  Formal 23 (21.5) 12 (41.4) 11 (14.1) 
  
      BMI status    n (%) 
     <18.5 5 (4.7) 4 (13.8) 1 (1.3) 12.400 0.006 
18.5-24.9 38 (35.5) 14 (48.3) 24 (30.8) 
  25-29.9 35 (32.7) 7 (24.1) 28 (35.9) 
  >30 29 (27.1) 4 (13.8) 25 (32.1) 
  
      Albuminuria   N(%) 
     Normoalbuminuria 83 (77.6) 22 (75.9) 61 (78.2) 0.0667 0.7962 
microalbuminuria 24 (22.4) 7 (24.1) 17 (21.8) 
  
      Type of HPT n (%) 
     Optimal 30 (28.0) 9(31.0) 21 (26.9) 3.453 0.327 
Normal 18 (16.8) 7(24.1) 11 (14.1) 
  High-normal 19 (17.8) 6 (20.7) 13 (16.7) 
  ISH  40 (37.4) 7 (24.1) 33 (42.3) 
  
      Type of diabetes 
     Type 1 10 (9.3) 3 (10.3) 7 (9.0) 0.047 0.829 
Type 2 97 (90.7) 26 (89.7) 71 (91.0) 
  
Table 2 shows the mean age, clinical parameters, BMI and 
FBG of  normotensives compared to ISH participants. 
Participants with ISH were older (P=0.02) and had FBG 
(P=0.034) than the normotensives. The mean DBP, SG 
and BMI were higher in participants with ISH than nor-
motensives (P>0.05). The urine pH was, however, higher 
in the normotensives than those with ISH though statis-
tically insignificant (P=0.057). 
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Table 3 describes the association between ISH and the 
type of  diabetes. Out of  the 40 diabetics with ISH, 40 
(100%) had type II diabetes whereas none had type I di-
abetes. Type of  diabetes was significantly associated with 
ISH (P=0.010).






no yes X2 P-value 
 
n=67 n=40 
  Type of diabetes 
    Type I 10 (14.9) 0 (0.0) 6.586 0.010 
Type II 57 (85.1) 40 (100.0) 
     
 Table 4 presents the association between hypertension, 
age and BMI. Majority of  the diabetics with ISH were in 
their fifties and sixties and obese. Age was significantly 
associated with hypertension (P =0.037) 
Table 4: Association between hypertension, Age and BMI 
 
 
Hypertension status  (Χ2) P-value 
 
Optimal Normal  High-normal ISH 
  Variables n=30 n=13 n=19 n=40     
Age 
      <40 10 (33.3) 4 (22.2) 2 (10.5) 4 (10.0) 22.050 0.037 
40-49 6 (20.0) 6 (33.3) 5 (26.3) 6 (15.0) 
  50-59 12 (40.0) 6 (33.3) 7 (30.8) 12 (30.0) 
  60-69 2 (6.7) 1 (5.6) 2 (10.5) 12 (30.0) 
  ≥ 70 0 (0.0) 1 (5.6) 3 (15.8) 6 (15.0) 
  
       BMI status 
      <18.5 2 (6.7) 0 (0.0) 2 (10.5) 1 (2.5) 13.173 0.155 
18.5-24.9 15 (50.0) 8 (44.4) 3 (15.8) 12 (30.0) 
  25-29.9 10 (33.3) 4(22.2) 8 (42.1) 13 (32.5) 
  >30 3 (10.0) 6 (33.3) 6 (31.6) 14 (35.0) 
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Variable Normotensive ISH P-value 
Age 48.44 ± 11.6 56.20 ± 10.60 0.022 
DBP 81.10 ± 5.83 83.50 ±7.30 0.192 
SG 1.02 ± 0.01 1.030 ± 0.04 0.513 
Ph 6.44 ± 0.72 6.32 ± 0.79 0.577 
BMI 25.59 ± 1.89 28.80 ± 1.71 0.091 
FBG 6.01 ± 0.50 8.80 ± 3.06 0.034 
 
Table 2: Mean age, clinical parameters, BMI and FBG of 
Normotensive compared to ISH participants 
Table 5 shows the multivariate logistic regression of  pre-
dictive factors of  ISH among our participants. Age was 
a significant risk factor of  ISH (OR=1.057, P=0.008). 
FBG, microalbuminuria, occupation and obesity were not 
associated with the risk of  ISH (P> 0.05). 
Table 5: Logistic regression of predictive factors associated with ISH 
  
  P-value. OR 95% C.I. 
Variables Lower Upper 
Age 0.008 1.057 1.014 1.102 
FBG 0.523 0.964 0.861 1.079 
Microalbuminuria 0.139 0.460 0.165 1.286 
Occupation 0.273 3.749 0.352 9.884 
Obesity 0.127 0.478 0.186 1.233 




Cardiovascular disease is the leading cause of  morbid-
ity and mortality among patients with diabetes mellitus 
(Stratton et al., 2000). In this study, we determined the 
prevalence and determinants of  isolated systolic hyper-
tension (ISH) in diabetics within the Tamale metropolis, 
Ghana.  This is the first study to report the prevalence 
and associated risk factors of  ISH among both type 1 
and 2 diabetes patients in Ghana. Our findings indicate 
that 37.4% of  type 2 diabetics had isolated systolic hyper-
tension (ISH). FBG was significantly higher in ISH than 
in normotensive and age was an independent risk factor 
of  ISH. 
The prevalence of  ISH among persons with type 2 diabe-
tes observed in our study is higher than that recorded by 
Brenyah et al. (2013) among type 2 diabetics in a random-
ized cross-sectional study in Kumasi, Ghana. This could 
be attributed to the purposive sampling used in their study 
and the socio economic variations amongresidents in Ku-
masi and Tamale. The higher literacy rate and economic 
status of  people in Kumasi compared to Tamale might 
have contributed to the higher ISH prevalence found in 
our study compared to Brenyah et al. (2013).
Cheung and Li (2012) reported common pathophysiolog-
ic pathways between obesity and diabetes. This is sup-
ported by the finding of  higher mean FBG among diabe-
tespatients with ISH compared to the normotensives. In 
type 2 diabetes, there is insulin resistance which results in 
impaired lipid catabolism and obesity which can lead to 
the development of  hypertension. Also, hyperglycaemia 
causes arterial stiffness and increased vascular tone result-
ing in systolic hypertension (Cheung and Li, 2012).
ISH was found only in type 2 diabetes. This is in conso-
nance with Grossman & Messerli (2008) who reported 
hypertension as a risk factor of  type 2 diabetes. This is in 
agreement with the findings of  Pinto (2007) who demon-
strated an elevation in systolic but not diastolic pressure 
in patients aged 50 or over. This might be associated with 
structural changes in the arteries especially with large ar-
tery stiffness, and losses in arterial compliance particular-
ly after the age of  40 (Pinto, 2007; Franklin et al., 2001). 
This is further supported by the logistic regression reveal-
ing age to be a risk factor for the development of  ISH. 
The older age in type 2 diabetes therefore contributes to 
the high systolic blood pressure observed among them.
The co-existence of  diabetes and isolated systolic hy-
pertension in the same patient is devastating to the car-
diovascular system and blood pressure control in these 
patients is a great challenge, since the target blood pres-
sure is lower and the response to treatment is poor. This 
comorbidity results in more severe cardiomyopathy than 
would be expected with either hypertension or diabetes 
mellitus alone.  The risk of  macrovascular and microvas-
cular complications in type 2 diabetes is strongly associ-
ated with systolic blood pressure (Stratton et al., 2000). 
Therefore, effective and easily accessible measures should 
be put in place to reduce the high systolic blood pressure 
among type 2 diabetes patients.
African Health Sciences Vol 16 Issue 4, December, 20161155
This study is limited by the use of  a smaller sample size 
and the cross-sectional design of  our study which pre-
cluded drawing of  a pathophysiological causal inference 
of  ISH in diabetes.
Conclusion
Isolated systolic hypertension was prevalent in 37.4% of  
diabetics and was only found in type 2 diabetes.  Higher 
age was a risk factor of  ISH. Effective measures should 
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